Ipsen SA IPSEF:OTCPK

*Data is delayed | Exchange | USD
Last | 03/14/24 EDT
117.60UNCH (UNCH)
52 week range
108.75 - 123.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close117.60
  • 52 Week High123.75
  • 52 Week High Date07/18/23
  • 52 Week Low108.75
  • 52 Week Low Date11/29/23

Key Stats

  • Market Cap9,617.8M
  • Shares Out82.64M
  • 10 Day Average Volume-
  • Dividend1.29
  • Dividend Yield1.10%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close117.60
  • 52 Week High123.75
  • 52 Week High Date07/18/23
  • 52 Week Low108.75
  • 52 Week Low Date11/29/23
  • Market Cap9,617.8M
  • Shares Out82.64M
  • 10 Day Average Volume-
  • Dividend1.29
  • Dividend Yield1.10%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)8.60
  • P/E (TTM)13.68
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/02/2023
  • Div Amount1.20
  • Split Date-
  • Split Factor-

Latest On Ipsen SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and...
Marc De Garidel
Chairman of the Board
Antoine Flochel
Vice Chairman of the Board
David Loew
Chief Executive Officer, Director
Aymeric Le Chatelier
Chief Financial Officer, Executive Vice President
Francois Garnier
Executive Vice President, General Counsel, Chief Business Ethics Officer
Address
65 Quai Georges Gorse
Boulogne-billancourt
92100
France